Terms: = Liver cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
24 results:
1. Development and validation of the first HBV qRT-PCR assay in the Mediterranean area targeting the X region.
Madihi S; Laassili C; Boukaira S; Baha W; Khyatti M; Zyad A; Ben Mkaddem S; Benani A
J Virol Methods; 2024 May; 326():114913. PubMed ID: 38452821
[TBL] [Abstract] [Full Text] [Related]
2. Metronomic capecitabine with rapamycin exerts an immunosuppressive effect by inducing ferroptosis of CD4
Wang H; Yang R; Wang Z; Cao L; Kong D; Sun Q; Yoshida S; Ren J; Chen T; Duan J; Lu J; Shen Z; Zheng H
Int Immunopharmacol; 2023 Nov; 124(Pt A):110810. PubMed ID: 37625370
[TBL] [Abstract] [Full Text] [Related]
3. Elevated nuclear PIGL disrupts the cMyc/brd4 axis and improves PD-1 blockade therapy by dampening tumor immune evasion.
Yu H; Shi T; Yao L; Xu D; Ding Y; Xia Q; Liu W; Wang X
Cell Mol Immunol; 2023 Aug; 20(8):867-880. PubMed ID: 37280393
[TBL] [Abstract] [Full Text] [Related]
4. Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty liver Disease and Advanced liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.
Liu CF; Chien LW
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111111
[TBL] [Abstract] [Full Text] [Related]
5. LINC02870 facilitates SNAIL translation to promote hepatocellular carcinoma progression.
Guo M; Zhuang H; Huang J; Shao X; Bai N; Li M; Niu M; Wei W; Sun L; Li Y; Qiang Z
Mol Cell Biochem; 2023 Sep; 478(9):1899-1914. PubMed ID: 36583796
[TBL] [Abstract] [Full Text] [Related]
6. Circular RNA as a Novel Biomarker and Therapeutic Target for HCC.
Meng H; Niu R; Huang C; Li J
Cells; 2022 Jun; 11(12):. PubMed ID: 35741077
[TBL] [Abstract] [Full Text] [Related]
7. Surgical Track and Scalp Implantation Following Intraventricular Meningiomas Excision: A Report with Review of Literature.
Rai HIS; Singh J; Singh M; Singh J; Gupta AK; Samala R; Veerabhadaraiah P; Nambirajan A
Neurol India; 2022; 70(1):31-36. PubMed ID: 35263850
[TBL] [Abstract] [Full Text] [Related]
8. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
[TBL] [Abstract] [Full Text] [Related]
9. Impact of bromodomain-containing protein 4 (brd4) and intestine-specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma' for better clarity.
Chuang KT; Wang SN; Hsu SH; Wang LT
Cancer Med; 2021 Aug; 10(16):5545-5556. PubMed ID: 34173348
[TBL] [Abstract] [Full Text] [Related]
10. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
[TBL] [Abstract] [Full Text] [Related]
11. Primary intrapulmonary malignant peripheral nerve sheath tumor: A rare case.
Maane LA; Bouzidi AA; Damou M; Ismaili N
Cancer Treat Res Commun; 2020; 25():100243. PubMed ID: 33260029
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of hepatic drug-metabolism for glioblastoma using liver-brain chip.
Li Z; Li D; Guo Y; Wang Y; Su W
Biotechnol Lett; 2021 Feb; 43(2):383-392. PubMed ID: 33145669
[TBL] [Abstract] [Full Text] [Related]
13. Circular RNA is a popular molecule in tumors of the digestive system (Review).
Wang HY; Wang YP; Zeng X; Zheng Y; Guo QH; Ji R; Zhou YN
Int J Oncol; 2020 Jul; 57(1):21-42. PubMed ID: 32377736
[TBL] [Abstract] [Full Text] [Related]
14. Cullin-3/KCTD10 complex is essential for K27-polyubiquitination of EIF3D in human hepatocellular carcinoma HepG2 cells.
Maekawa M; Hiyoshi H; Nakayama J; Kido K; Sawasaki T; Semba K; Kubota E; Joh T; Higashiyama S
Biochem Biophys Res Commun; 2019 Sep; 516(4):1116-1122. PubMed ID: 31280863
[TBL] [Abstract] [Full Text] [Related]
15. Dilemmas in Diagnosis and Management of Gastroenteropancreatic Mixed Neuroendocrine Non-neuroendocrine Neoplasms: First Single-Centre Report from India.
Desai GS; Pande P; Shah RC; Jagannath P
J Gastrointest Cancer; 2020 Mar; 51(1):102-108. PubMed ID: 30784017
[TBL] [Abstract] [Full Text] [Related]
16. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma.
Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM
Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918
[TBL] [Abstract] [Full Text] [Related]
17. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.
Xiong L; Wu F; Wu Q; Xu L; Cheung OK; Kang W; Mok MT; Szeto LLM; Lun CY; Lung RW; Zhang J; Yu KH; Lee SD; Huang G; Wang CM; Liu J; Yu Z; Yu DY; Chou JL; Huang WH; Feng B; Cheung YS; Lai PB; Tan P; Wong N; Chan MW; Huang TH; Yip KY; Cheng AS; To KF
Nat Commun; 2019 Jan; 10(1):335. PubMed ID: 30659195
[TBL] [Abstract] [Full Text] [Related]
18. PES1 is transcriptionally regulated by brd4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.
Fan P; Wang B; Meng Z; Zhao J; Jin X
Int J Biochem Cell Biol; 2018 Nov; 104():1-8. PubMed ID: 30172011
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic reader brd4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.
Hong SH; Eun JW; Choi SK; Shen Q; Choi WS; Han JW; Nam SW; You JS
Oncotarget; 2016 May; 7(22):32628-40. PubMed ID: 27081696
[TBL] [Abstract] [Full Text] [Related]
20. Downregulation of miR-329 promotes cell invasion by regulating brd4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract] [Full Text] [Related]
[Next]
